fludarabine
Showing 1 - 25 of 622
Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)
Not yet recruiting
- Relapsed/Refractory Large B Cell Lymphoma
- ALLO-647
- +3 more
- (no location specified)
Feb 6, 2023
Acute Myeloid Leukemia, Core-Binding Factor Trial in Shanghai (Fludarabine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Core-Binding Factor
- Fludarabine
- Cytarabine
-
Shanghai, Shanghai, ChinaXianmin Song
May 5, 2022
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- Fludarabine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Adult T-Cell Leukemia (ATL)
- LMB-2
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 13, 2022
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow
Terminated
- Acute Myeloid Leukemia
- +3 more
- Fludarabine
- Total Marrow Irradiation (TMI)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Feb 22, 2022
Fludarabine Drug Exposure in Pediatric Bone Marrow
Completed
- Hematologic Malignancies
- +7 more
- Fludarabine
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)
Active, not recruiting
- Adult Lymphoblastic Lymphoma
- Fludarabine
- Total Body Irradiation
-
Birmingham, AlabamaUAB Bone Marrow Transplantation and Cellular Therapy Program
Apr 11, 2022
T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)
Recruiting
- T-cell Non-Hodgkin Lymphoma
- Lymphoma, Extranodal NK-T-Cell
- Busulfan
- Fludarabine
-
Busan, Korea, Republic of
- +1 more
Aug 17, 2022
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Nanjin (Orelabrutinib, Obinutuzumab, Fludarabine)
Recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Orelabrutinib
- +3 more
-
Nanjin, Jiangsu, ChinaDepartment of Haematology, the First Affiliated Hospital of Nanj
Apr 12, 2022
Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- IPI-145
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 10, 2022
Aplastic Anemia, Neutropenia, Pancytopenia Trial run by the NHLBI (Cyclophosphamide, Fludarabine)
Completed
- Aplastic Anemia
- +3 more
- Cyclophosphamide
- Fludarabine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 7, 2021
Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)
Recruiting
- Hematologic Diseases
- allogeneic γ9δ2 T Cells
- +3 more
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Feb 23, 2023
Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,
Recruiting
- Leukemia, Acute Lymphoblastic
- +5 more
- Fludarabine
- +5 more
-
Saint Petersburg, Russian FederationRM Gorbacheva Research Institute
Jun 21, 2021
Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)
Recruiting
- Myelogenous Leukemia, Acute
- Bisantrene
- +2 more
-
Ramat Gan, IsraelChaim Sheba Medical Center
Sep 21, 2021
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Fludarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)
Active, not recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Hackensack, New JerseyHackensack University Medical Center
Feb 4, 2022
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 15, 2022
Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin's Lymphoma
- Allogenic CD19-CAR-γδT cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Jan 31, 2023
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- +3 more
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
May 25, 2021
Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)
Not yet recruiting
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +2 more
- (no location specified)
Mar 3, 2022
Acute Myeloid Leukemia, Adult, AML, AML, Adult Trial in La Jolla (Fludarabine, Vyxeos)
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine
- Vyxeos
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Mar 30, 2021
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Leukemia
- Fludarabine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 11, 2021